Fidelity International’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,571
Closed -$574K 834
2022
Q2
$574K Buy
2,571
+1,101
+75% +$369K ﹤0.01% 745
2022
Q1
$808K Buy
+1,470
New +$888K ﹤0.01% 742
2021
Q4
Sell
-6,000
Closed -$5.04M 818
2021
Q3
$5.04M Sell
6,000
-12,131
-67% -$12.3M 0.01% 603
2021
Q2
$23M Buy
+18,131
New +$20.5M 0.02% 435

Other funds holding CDLX

Fidelity International's CDLX Position: Q3 2022 in Review

Fidelity International sold out of Cardlytics (CDLX) in Q3 2022, closing a stake of 2,571 shares — an estimated $574K sold.

Fidelity International first reported a position in CDLX in Q2 2021 and held it in 4 quarters. The position peaked at $23M in Q2 2021. 132 funds tracked by Wall St. Rank hold CDLX as of Q3 2022.

  • Fidelity International reported no remaining Cardlytics position as of Q3 2022 after selling out during the quarter.
  • Fidelity International sold 2,571 Cardlytics shares in Q3 2022, an estimated $574K.
  • Fidelity International first reported a position in Cardlytics in Q2 2021 and held it in 4 quarters.
  • Fidelity International's Cardlytics position peaked at $23M in Q2 2021.
  • 132 funds tracked by Wall St. Rank held Cardlytics as of Q3 2022.

Based on Fidelity International's 13F filing for Q3 2022, filed 10 Nov 2022.